In her-2/neu-positive lesions, COX-2 overexpression is even more frequent and was observed in 43% of invasive breast carcinomas and in as many as 63% in ductal carcinomas in situ [4]. The gene discussed is PTGS2; the disease is invasive breast carcinoma.